Stockscreener 앱 받기
64.00
2.48%
-3.225
전일 마감가:
$67.23
열려 있는:
$66.3
하루 거래량:
129.43K
Relative Volume:
0.11
시가총액:
$3.21B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-20.58
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
-41.72%
1개월 성능:
-18.07%
6개월 성능:
-12.42%
1년 성능:
+233.47%
1일 변동 폭
$64.00
$66.30
1주일 범위
$61.55
$117.75
52주 변동 폭
$18.80
$117.75
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
WGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
64.15 | 3.21B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
419.81 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.45 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
468.79 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
108.28 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.30 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
Why Investors Were Avoiding GeneDx Holdings Stock This Week - AOL.com
Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces - Hartford Business Journal
With A 26% Price Drop For GeneDx Holdings Corp. (NASDAQ:WGS) You'll Still Get What You Pay For - simplywall.st
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why - MSN
GeneDx plunges despite Q1 beat and guidance raise - MSN
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates - MSN
GeneDx price target lowered to $78 from $105 at Wells Fargo - TipRanks
GeneDx price target lowered to $100 from $115 at BTIG - TipRanks
GeneDx Holdings (WGS) Price Target Lowered by TD Securities | WG - GuruFocus
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fa - GuruFocus
GeneDx stock target cut to $100 by BTIG, maintains Buy rating - Investing.com Nigeria
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fargo | WGS Stock News - GuruFocus
GeneDx earnings selloff a buying opportunity, says Craig-Hallum - Yahoo Finance
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Perfor - GuruFocus
GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stoc - GuruFocus
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript - Insider Monkey
GeneDx (WGS) Sees Price Target Cut But Retains Buy Rating | WGS Stock News - GuruFocus
Wells Fargo Adjusts Price Target for GeneDx (WGS) Amid Market Fl - GuruFocus
WGS Reports Strong Q1 Revenue, Outpaces Expectations | WGS Stock News - GuruFocus
GeneDx Reports Strong Q1 2025 Growth and Expansion Plans - TipRanks
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat - MSN
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat By Stocktwits - Investing.com India
GeneDx Holdings Corp. Reports Strong Earnings and Strategic Growth - TipRanks
GeneDx (WGS) Stock Decline Viewed as Buying Opportunity | WGS St - GuruFocus
GeneDx: A Diagnostic Company's Stock Takes a Hit Amidst Earnings Beat and Guidance Raise - RagingBull
Why GeneDx Holdings Stock Is Plunging Today - AOL.com
GeneDx Holdings earnings missed by $0.29, revenue topped estimates - Investing.com South Africa
Why GeneDx Holdings Stock Is Plunging Today - The Motley Fool
GeneDx stock plunges despite Q1 beat (WGS:NASDAQ) - Seeking Alpha
Earnings call transcript: GeneDx Q1 2025 misses EPS, stock plummets - Investing.com
GeneDx Q1 2025 slides: revenue jumps 42%, raises guidance on Fabric acquisition - Investing.com Australia
GeneDx Q1 Loss Narrows, Revenue Rises; 2025 Revenue Outlook Raised - marketscreener.com
GeneDx Holdings Corp. SEC 10-Q Report - TradingView
GeneDx Reports First Quarter 2025 Financial Results and Business Highlights - TradingView
Earnings Flash (WGS) GeneDx Holdings Posts Q1 Loss of $0.23 per Share, vs. FactSet Est of $0.27 Loss per Share - marketscreener.com
GeneDx Holdings Corp. Provides Earnings Guidance for the Full Year 2025 - marketscreener.com
GeneDx (WGS) Set to Announce Q1 Earnings with Mixed Expectations - GuruFocus
GeneDx: Strengthening Leadership In Genomic Diagnostics (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings Corp. (WGS): Among the Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
10 Best Multibagger Stocks to Buy According to Billionaires - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? - MSN
(WGS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand - Insider Monkey
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition - Yahoo
GeneDx to acquire AI genomics firm Fabric Genomics By Investing.com - Investing.com South Africa
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million - Benzinga
GeneDx to Acquire Fabric Genomics for Up to $51 Million - marketscreener.com
GeneDx to acquire Fabric Genomics in a deal worth up to $51M - MSN
GeneDx Holdings Acquires Fabric Genomics for $33 Million - TipRanks
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Genedx Holdings Corp 주식 (WGS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Sale |
113.09 |
388 |
43,879 |
3,337 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Sale |
113.09 |
2,154 |
243,596 |
3,440 |
0.41%
0.01%
자본화:
|
볼륨(24시간):